AMRN Amarin Corporation plc

NASDAQ
$11.38

Amarin Corporation plc (AMRN) is expected to report earnings on January 27, 2027, before the market open. The consensus earnings estimate is a loss of $0.31 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -6.7% since its last earnings release on October 28, 2026.

Amarin Corporation plc Beat Consensus Estimates
Wednesday, October 28, 2026 · 7:00 AM ET
Earnings Date
4th Quarter, Dec 2026
Jan 27
Wednesday · 7:00 AM ET
Earnings Whisper
-
vs ($0.31)
Rev est $47.71M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $11.99

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Amarin Corporation plc

Amarin Corp PLC is a biopharmaceutical company with expertise in lipid science. The Company is engaged in commercialization and development of therapeutics to improve cardiovascular health.

Sector

Healthcare

Industry

Drug Delivery

Charts powered in part by Lightweight Charts™ by TradingView.